Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06129409 · ClinicalTrials.gov registry record · Phase 1
Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease
A Phase 1 study of Cardiovascular Diseases, sponsored by NodThera Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 67
- Enrollment target
- 2
- Study locations
NCT06129409 is a Phase 1 study of Cardiovascular Diseases that has completed, run by NodThera Limited. The registered enrollment target is 67 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06129409, a Phase 1 study of Cardiovascular Diseases, has completed, sponsored by NodThera Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 67 participants
- Enrollment target
- 2
- Study locations
Study Summary
This trial is a Randomized, Double-Blind (Sponsor-Open), Placebo-Controlled Study to Assess the Effect of NT-0796 on Inflammation in Obese Participants at Risk of Cardiovascular Disease. Participants will be admitted to an in-patient Clinical Research Unit on Day -1 and will be discharged on Day 30. The trial will include a 7-day out-patient safety follow-up period following the last dose of study treatment. For the first approximately 20 participants effect of food will be evaluated on the Pharmacokinetics of NT-0796. MRI's will be conducted in a subset of participants.
Conditions Studied
Interventions
- DRUG NT-0796
Study Locations (2)
Florida
- Investigative Site - Miami
Texas
- Investigative Site - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2023-10-10 |
| Est. Completion | 2024-04-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06129409
The ClinicalTrials.gov registry entry for NCT06129409 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is NodThera Limited, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which NT-0796 is the first listed.
NCT06129409 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT06129409 about?
NCT06129409 is a clinical study titled "Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease". This trial is a Randomized, Double-Blind (Sponsor-Open), Placebo-Controlled Study to Assess the Effect of NT-0796 on Inflammation in Obese Participants at Risk of Cardiovascular Disease. Participants will be admitted to an in-patient Clinical Research Unit on Day -1 and will be discharged on Day 30...
What is the current status of trial NCT06129409?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 67 participants. The study started on 2023-10-10. Estimated completion is 2024-04-15.
What conditions does trial NCT06129409 study?
This clinical trial studies the following conditions: Cardiovascular Diseases.
What interventions are being tested in trial NCT06129409?
The interventions under investigation include: NT-0796 (DRUG).
Who is sponsoring clinical trial NCT06129409?
This trial is sponsored by NodThera Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06129409 being conducted?
This trial has 2 study locations across Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
RECRUITING · Phase 1
-
Prevention of Progression of Prediabetes, Obesity and CV Risk
RECRUITING · Phase 1
-
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
RECRUITING · Phase 1
-
AB-1002 in Patients With Class III Heart Failure
ACTIVE NOT RECRUITING · Phase 1
-
MRI-Guided Balloon Angioplasty to Treat Blood Flow Blockage in the Legs
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.